Evidence map›Paper›PMID 26051510›Full record

Trial reportThe British journal of nutrition2015

Adherence to cancer prevention recommendations and antioxidant and inflammatory status in premenopausal women.

Yukiko Morimoto, Fanchon Beckford, Robert V Cooney, Adrian A Franke, Gertraud Maskarinec

Open access · bronzeAbstract readRandomized Controlled Trial
In one paragraph

Trial report in The British journal of nutrition, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
1.1field-weighted citation impact, top 26% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 19 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 3 institutions in 1 country.

Yukiko MorimotoUniversity of Hawaii Cancer Center, Epidemiology Program,701 Ilalo Street,Honolulu,HI96813,USA.
Fanchon BeckfordUniversity of Hawaii Cancer Center, Epidemiology Program,701 Ilalo Street,Honolulu,HI96813,USA.
Robert V CooneyDepartment of Public Health Sciences, University of Hawaii,Honolulu,HI,USA.
Adrian A FrankeUniversity of Hawaii Cancer Center, Epidemiology Program,701 Ilalo Street,Honolulu,HI96813,USA.
Gertraud MaskarinecUniversity of Hawaii Cancer Center, Epidemiology Program,701 Ilalo Street,Honolulu,HI96813,USA.
University of Hawaiʻi at Mānoa · USUniversity of Hawaii System · USUniversity of Hawaii Cancer Center

Funding

University of Hawaii Cancer Center CCSGP30CA071789 · NCI · UNIVERSITY OF HAWAII AT MANOA · PI GERTRAUD MASKARINEC · 1996 to 2026
$56.2M
SOY EFFECTS ON ESTROGENS AND MAMMOGRAPHIC DENSITIESR01CA080843 · NCI · UNIVERSITY OF HAWAII AT MANOA · PI MASKARINEC, GERTRAUD · 1999 to 2010
$2.9M
NCI NIH HHS P30 CA071789NCI NIH HHS P30CA71789NCI NIH HHS R01 CA080843NCI NIH HHS R01CA80843
6 · The paper itself

Abstract

For cancer prevention, the World Cancer Research Fund and American Institute for Cancer Research (WCRF/AICR) emphasise recommendations to improve individual behaviour, including avoidance of tobacco products, maintaining a lean body mass, participating in physical activity, consuming a plant-based diet, and minimising the consumption of energy-dense foods, such as sodas, red and processed meats and alcohol. In the present study of 275 healthy premenopausal women, we explored the association of adherence scores with levels of three biomarkers of antioxidant and inflammation status: serum C-reactive protein (CRP), serum γ-tocopherol and urinary F2-isoprostane. The statistical analysis applied linear regression across categories of adherence to WCRF/AICR recommendations. Overall, seventy-two women were classified as low ( ≤ 4), 150 as moderate (5-6), and fifty-three as high adherers ( ≥ 7). The unadjusted means for CRP were 2.7, 2.0 and 1.7 mg/l for low, moderate and high adherers (P trend= 0.03); this association was strengthened after adjustment for confounders (P trend= 0.006). The respective values for serum γ-tocopherol were 1.97, 1.63 and 1.45 μg/ml (P trend= 0.02 before and P trend= 0.03 after adjustment). Only for urinary F2-isoprostane, the lower values in high adherers (16.0, 14.5, and 13.3 ng/ml) did not reach statistical significance (P trend= 0.18). In an analysis by BMI, overweight and obese women had higher biomarker levels than normal weight women; the trend was significant for CRP (P trend< 0.001) and γ-tocopherol (P trend= 0.003) but not for F2-isoprostane (P trend= 0.14). These findings suggest that both adherence to the WCRF/AICR guidelines and normal BMI status are associated with lower levels of biomarkers that indicate oxidative stress and inflammation.

Indexed as

Health BehaviorAdultAntioxidantsBiomarkersBody Mass IndexC-Reactive ProteinDietEnergy IntakeF2-IsoprostanesFemalegamma-TocopherolHumansInflammationMiddle AgedNeoplasmsObesityAntioxidantsBiomarkersC-Reactive ProteinF2-Isoprostanesgamma-TocopherolCancer preventionChronic inflammationLifestyleNutritionRecommendations

Identifiers

PMID26051510
PMCPMC4838598
OpenAlexW2197017662

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.